Lot certificates published
Plain, secure packaging
All certificates of analysisRetatrutide 30mg product page

Retatrutide 30mg

Results reported for the submitted sample

Retatrutide 30mg

Lot in our record
RET-20260811-01
Certificate ID
COA7920
Lot printed on the certificate
RET-20260811-02

Lot linkage is unresolved: lot in our record RET-20260811-01; lot printed on the certificate RET-20260811-02.

Bioviridian Inc. · COA7920

Reported identity
Retatrutide
LC-MS/MS
Measured content / assay
30.88 mg
HPLC Quantitation
Chromatographic purity
99.82%
RP-HPLC (214 nm)

Testing scope

Results are reported for the submitted sample. They do not establish the identity or composition of every vial carrying a lot label.

We have not commissioned sterility or endotoxin testing for this material. This is the owner's statement about Purely Peptides' commissioning, not a claim about testing by upstream parties.

This report does not include a residual-solvent result.

These results do not establish suitability for human or veterinary use.

Independent issuer confirmation has not been recorded for this assessment. A hosted PDF or report code does not establish authenticity or physical-sample linkage.

Additional laboratory results (2)

Krause Analytical LLC · sample ksytstq · Lab #214171

Tested by Krause Analytical LLC; commissioned through Finnrick.

The certificate’s Batch/Lot field shows the Finnrick sample code ksytstq. We list this result under lot RET-20260811-01.

Chromatographic purity
99.3%
Method: HPLC-UV/MS
Measured content
28.7 mg
Method: HPLC-UV-MS
Identity (mass spectral match)
ID Confirmed
Method: HPLC-UV-MS
Label claim
30 mg
% of label, as printed
95.6
COC#
145871
Received
2026-09-18
Analyzed
2026-09-25
Report issued
2026-10-01
Laboratory address
8127 Mesa Drive Suite B-206, Austin, TX 78759
Laboratory director
Mark C. Krause
PDF SHA-256
af3a211da9ed8c4006d539d0a59c80b37fd79bbecd45ae2020083ad70869055c
Original full certificate (PDF) · ksytstq

Krause Analytical LLC · sample xbhwgh9 · Lab #214170

Tested by Krause Analytical LLC; commissioned through Finnrick.

The certificate’s Batch/Lot field shows the Finnrick sample code xbhwgh9. We list this result under lot RET-20260811-01.

Chromatographic purity
>99.9%
Method: HPLC-UV/MS
Measured content
28.0 mg
Method: HPLC-UV-MS
Identity (mass spectral match)
ID Confirmed
Method: HPLC-UV-MS
Label claim
30 mg
% of label, as printed
93.3
COC#
145871
Received
2026-09-18
Analyzed
2026-09-25
Report issued
2026-10-01
Laboratory address
8127 Mesa Drive Suite B-206, Austin, TX 78759
Laboratory director
Mark C. Krause
PDF SHA-256
30dddd9387a1b8b06b344b260b345b5a1f1180741773a332d849fee6725c2713
Original full certificate (PDF) · xbhwgh9

Issuer and report details

Bioviridian Inc. is named on the certificate as the issuing laboratory. Independent issuer confirmation has not been recorded for this assessment (not checked).

Check the report with the issuing laboratory

Use certificate ID COA7920. Issuer confirmation would not by itself establish all-vial or physical-sample linkage.

Methods, reporting context and disclosure provenance
Sample type
White lyophilized powder
Molecular weight (g/mol), as recorded
4731.2
Sample received
2026-08-18
Report issued
2026-08-23
HPLC retention time, as recorded
11.801 min

Results and methods retain the report record's original units and precision. A result here is not a finding that an acceptance specification was met.

Source: page 1, Test Results, Sample Information and Analytical Methods. Document annotations were visually inspected on 2026-10-10; no new laboratory authentication has been performed.

Commissioning disclosure: Purely Peptides owner's statement in the editorial and batch-results brief, bound to this inspected report and material. It is separate from document-derived absence of a residual-solvent result.

Published by Purely Peptides, a commercial research-material supplier. These documentation pages do not establish suitability for human or veterinary use.